Examples of using Mylan in English and their translations into Hebrew
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
-
Programming
Mylan said earlier this month it would pay $465 million to settle questions over whether it underpaid U.S. government healthcare programs by misclassifying the EpiPen anti-allergy drug delivery device.
As announced on April 21, 2015, Teva proposed to acquire Mylan for $82.00 per Mylan share, with the consideration to be comprised of approximately 50 percent cash and 50 percent stock.
We certainly hope that the Mylan Board of Directors chooses to engage constructively with us as soon as possible
The new company, which combines the unique assets of Mylan with the iconic brands of Pfizer's Upjohn business,
Since announcing the proposal to acquire Mylan on April 21,
Clinton's campaign cited Turing Pharmaceuticals LLC's raising the price of its AIDS drug Daraprim(pyrimethamine) and Mylan NV's repeated steep price increases on EpiPen for severe allergy sufferers as“troubling” examples of price hikes that have attracted bipartisan congressional scrutiny.
His name was Farrol Mylan.
Teva filed a lawsuit suit against Mylan in October 2010.
Mylan has hiked the price of dozens of other medications, as well.
Teva offered to acquire Mylan for $82 per share in cash and stock.
Teva proposes to acquire Mylan for $82 per share in cash and stock.
In your view, can Mylan produce a generic Copaxone identical to that of Teva?
So Mylan already needs a large quantity of the active ingredient now.
We saw a drug company, Mylan, excessively raise the price of lifesaving EpiPens without justification.
Mylan President Rajiv Malik was named in a separate complaint filed by state attorneys general in 2017.
The Mylan board of directors is composed half of management,
Mylan has dealt with the pressure to lower EpiPen prices by diversifying its product portfolio and geographic expansion.
Mylan is doubling eligibility for its patient assistance program to 400 percent of the federal poverty level.
Mylan also is doubling eligibility for our patient assistance program to 400% of the federal poverty level.
Coury, who contemptuously rejected Teva's offer of $82 per Mylan share, is now satisfied with a much poorer deal.